Millennium Management LLC has recently announced that it has increased stake in ThermoGenesis Holdings Inc. (NASDAQ:THMO) by 1,360.75%. After grabbing 14739.0 shares, the institutional investor is now in possession of 13730.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.42% having worth around $47460.0. Moreover, Morgan Stanley & Co. LLC increased its share by 2469.0 to have a control over 2624.0 shares. And Tower Research Capital LLC raised its holdings to 860.0 shares by acquiring 891.0 shares or 0.09% of the stake.
ThermoGenesis Holdings Inc. (THMO) concluded trading on 03/16/23 at a closing price of $6.00, with 28.34 million shares of worth about $170.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.69% during that period and on Thursday the price saw a gain of about 43.20%. Currently the company’s common shares owned by public are about 31.27M shares, out of which, 0.75M shares are available for trading.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the THMO stock and their offered price forecasts bring an average price target of $45.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $45.00 and could fall to a lowest price of $45.00. The stock’s current price level is 86.67% above of average price target set by the analysts, while a rise to estimated low would result in gain of 86.67% for the stock. However, touching the estimated high of $45.00 would mean a gain of 86.67% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 1 times over the past 12 months. They bought 10,552,234 shares in 1 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Series Total Market Inde, and Fidelity Extended Market Index Fu are the top 3 mutual funds which are holding stakes in ThermoGenesis Holdings Inc. Vanguard Extended Market Index Fu is currently holding 2709.0 shares of worth totaling $8723.0. The company recently came buying 0.0 shares which brought its stake up to 0.26% of the company’s outstanding shares. Fidelity Series Total Market Inde bought 1442.0 shares, after which its hold over company’s outstanding shares expand to 0.15%, leaving 1538.0 shares with the mutual fund that have a worth of about $4952.0. Fidelity Extended Market Index Fu, after buying 707.0 shares, have now control over 0.07% of the stake in the company. It holds 0.0 shares of worth $2277.0.
ThermoGenesis Holdings Inc. (NASDAQ: THMO) started trading at $4.50, above $0.31 from concluding price of the previous day. However, the stock later moved at a day high price of 6.23, or with a gain of 43.20%. Stock saw a price change of 143.90% in past 5 days and over the past one month there was a price change of 76.99%. Year-to-date (YTD), THMO shares are showing a performance of 87.50% which decreased to -76.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.11 but also hit the highest price of $40.49 during that period. The average intraday trading volume for ThermoGenesis Holdings Inc. shares is 625.92K. The stock is currently trading 104.82% above its 20-day simple moving average (SMA20), while that difference is up 75.87% for SMA50 and it goes to -23.67% lower than SMA200.
Millennium Management LLC acquired 14739.0 shares of ThermoGenesis Holdings Inc. having value of about $47460.0. Data submitted at the U.S SEC by Millennium Management LLC revealed that the firm now holds 13730.0 shares in the company valued at close to $82380.0, or have control over 1,360.75% stake in the company. ThermoGenesis Holdings Inc. (NASDAQ: THMO) currently have 31.27M outstanding shares and institutions hold larger chunk of about 1.40% of that. Holding of mutual funds in the company is about 0.49% while other institutional holders and individual stake holders have control over 1.42% and — of the stake respectively.
The stock has a current market capitalization of $6.90M and its 3Y-monthly beta is at 2.59. It has posted earnings per share of -$0.68 in the same period. It has Quick Ratio of 0.60 while making debt-to-equity ratio of 1.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for THMO, volatility over the week remained 23.23% while standing at 12.30% over the month.
Analysts are in expectations that ThermoGenesis Holdings Inc. (THMO) stock would likely to be making an EPS of -$0.9 in the current quarter, while forecast for next quarter EPS is -$0.45 and it is -$1.35 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.9 which is -$0.9 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$17.1 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 63.00%.
Analysts at 1 brokerage firms have issued recommendations for the ThermoGenesis Holdings Inc. (THMO)’s stock out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
On November 17, 2015, Maxim Group Reiterated their recommendations, while on September 21, 2015, H.C. Wainwright Upgrade their ratings for the stock with a price target of $2. Stock get a Neutral rating from H.C. Wainwright on May 15, 2015.
